Physician profile
Jagjit Singh
NPI 1801884929
$565.40
in general payments reported to CMS, 2019-2025
9 companies · $54.39 in 2025
The $54.39 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $33.52 · 2022: $12.14 · 2023: $27.10 · 2025: $54.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.22 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.22 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $203.05 | 2019 | |
| Akebia Therapeutics INC | $150.84 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $46.12 | 2019 | |
| Amgen INC. | $44.79 | 2019 | |
| Novo Nordisk INC | $32.27 | 2025 | |
| Alkermes, INC. | $27.10 | 2023 | Vivitrol |
| Vifor Pharma, INC. | $23.02 | 2019-2022 | |
| Lilly USA, LLC | $22.12 | 2025 | Mounjaro |
| Alexion Pharmaceuticals, INC. | $16.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagjit Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.